This Blew My Mind
🦎 Did You Know? The First GLP-1 Drug Came From a Lizard! 💉
Okay, I HAVE to share this because it's one of the most fascinating stories I've come across while learning about GLP-1 medications! 😂
Did you know that a discovery involving a venomous lizard helped lead to the very first FDA-approved GLP-1 receptor agonist for treating type 2 diabetes?
And yes...
This is a TRUE story! 🦎
Let's talk about how a lizard called the Gila monster helped change diabetes treatment forever!
🦎 Meet the Gila Monster
The Gila monster (pronounced HEE-luh) is a venomous lizard native to the southwestern United States and northwestern Mexico.
It's known for its:
🦎 Large body
🟠 Orange, pink, and black patterned skin
🌵 Desert habitat
🍽️ Ability to go long periods between meals
But what makes this lizard REALLY interesting isn't just its appearance.
It's something scientists discovered in its venomous saliva!
🔬 The Discovery That Changed Everything
In 1990, a scientist named Dr. John Eng was studying substances found in Gila monster venom.
He discovered a peptide called:
Exendin-4
And here's where things got interesting...
Exendin-4 behaved a LOT like a hormone researchers were already studying in humans.
That hormone?
GLP-1!
Yes, the SAME GLP-1 receptor system we talk about in our community today!
But there was something special about the lizard's peptide.
It lasted much longer in the body than natural human GLP-1.
And that caught researchers' attention!
💉 Why Was This Such a Big Deal?
Scientists already knew that GLP-1 could help regulate blood sugar.
One of the ways it does this is by signaling the pancreas to release insulin when blood sugar is elevated.
But there was a problem.
Natural human GLP-1 breaks down VERY quickly!
We're talking just a few minutes.
That made it challenging to use natural GLP-1 directly as a practical medication.
But Exendin-4?
It was much more resistant to the enzyme that breaks down GLP-1.
Which meant its effects could last much longer!
Think about it like this...
Imagine trying to send a message to your body.
📡 Natural GLP-1 sends the message, but the signal disappears quickly.
🦎 Exendin-4 activates the same receptor, but the signal can last much longer.
Researchers realized this could be incredibly useful for developing diabetes treatments.
🧬 Wait... Was Exendin-4 Actually GLP-1?
No!
And this is an important distinction.
Exendin-4 and human GLP-1 are NOT identical molecules.
Exendin-4 is a peptide made up of 39 amino acids.
It shares similarities with human GLP-1 and can activate the same GLP-1 receptor.
Remember what we learned about receptors?
Think of the receptor like a lock.
And a molecule that activates it like a key.
🔑 Human GLP-1 can activate the GLP-1 receptor.
🔑 Exendin-4 can ALSO activate that receptor.
Different molecules.
Similar receptor activity!
This is a perfect real-world example of how receptor agonists work.
🏥 From Lizard Venom to an FDA-Approved Medication
Now here's the part that REALLY amazed me!
Researchers didn't simply collect lizard venom and inject it into people.
They developed a synthetically manufactured version of Exendin-4.
That medication became known as:
Exenatide
And it was marketed under the brand name:
Byetta
On April 28, 2005, the FDA approved Byetta for treating type 2 diabetes in adults, initially alongside certain other diabetes medications.
And here's why that date matters...
🎉 Byetta became the FIRST FDA-approved GLP-1 receptor agonist!
A discovery involving a venomous desert lizard had helped lead to an entirely new category of diabetes medication.
How amazing is that?! 😂
📅 Let's Look at the Timeline
🧬 1980s
Scientists were learning more about human GLP-1 and how it affects insulin and blood sugar.
🦎 1990
Dr. John Eng identified Exendin-4 while investigating Gila monster venom.
🔬 1990s
Researchers continued studying Exendin-4 and its potential for diabetes treatment.
💉 Early 2000s
Exenatide underwent human clinical testing.
🎉 2005
The FDA approved Byetta (exenatide), the first GLP-1 receptor agonist medication.
And the research didn't stop there!
🧬 What About Today's GLP-1 Medications?
Fast-forward to today.
We now hear about medications and investigational peptides such as:
💉 Semaglutide
💉 Tirzepatide
💉 Retatrutide
💉 Survodutide
These are NOT simply copies of the Gila monster peptide.
They have different molecular designs, and some target additional receptors beyond GLP-1.
But the discovery of Exendin-4 helped demonstrate that activating the GLP-1 receptor could become a practical treatment strategy.
And that played an important role in the history of the medications we're discussing today!
🔎 One More Thing...
Here's what I find especially interesting about this story.
Scientists weren't originally trying to invent the next big weight-loss medication by studying a lizard.
They were investigating biological molecules and trying to understand what those molecules actually did.
One discovery led to another.
Researchers identified a peptide.
They investigated how it worked.
They studied its effects in animals.
Then they tested a synthetic version in humans.
And eventually...
An FDA-approved diabetes medication was developed.
That's such a great reminder of why scientific research matters!
A discovery that seems completely unrelated to human medicine can sometimes lead to something extraordinary.
And it also reminds us that developing a medication takes MUCH more than finding an interesting peptide.
Researchers still have to establish its safety and effectiveness through appropriate testing.
💛 Ashley's Take
I absolutely LOVE learning the history behind these medications!
We spend so much time talking about GLP-1, GIP, glucagon, receptors, and different peptides.
But sometimes I think it's easy to forget how these discoveries actually started.
The fact that a venomous lizard helped researchers develop the first GLP-1 medication is just fascinating to me!
And I think it's a perfect example of why understanding the science behind peptides is so important.
Sometimes the most unexpected discoveries lead to major medical advances.
Who would've thought we'd be talking about a Gila monster in a GLP-1 research community? 😂🦎
💬 Let's Talk!
Did you already know about the Gila monster's connection to GLP-1 medications?
Or is this the first time you've heard this story? 👀
And here's another question...
Does learning how these medications were originally discovered make you more interested in the science behind them?
I'd love to hear everyone's thoughts!
Because this is exactly why I enjoy learning and researching with all of you. 💛
Research, Not Guesswork. 💛
📚 Sources
National Institutes of Health (NIH) — Exendin-4: From Lizard to Laboratory and Beyond
NIH / NIDDK — The Discovery of Diabetes and Obesity Medications
U.S. Department of Veterans Affairs — Diabetes Drug From Gila Monster Venom
PubMed — The Development of Byetta From Gila Monster Venom
FDA — Byetta (Exenatide) Regulatory Review and Approval History
1
2 comments
Ashley Subject To Change
5
This Blew My Mind
powered by
Subject To Change Academy
skool.com/subject-to-change-academy-4743
Pull up a chair. Ask why. Stay curious. Research instead of guess. Normalize saying, "I'm confused."
Build your own community
Bring people together around your passion and get paid.
Powered by